Photodynamic Therapy-Induced Immune Modulation: Part III
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Actinic Keratosis
- Photodynamic Therapy
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 45 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03643744
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Jeffrey B Travers, MD, PhD Wright State Physicians